Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 3,853-3,864 of 5,650
Biological study icon
RecruitingNCT06221358

Pharmacogenomics of Stimulant Treatment Response

This observational study is following people with Attention-Deficit/ Hyperactivity Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Calgary
ADHDOtherFrom 6 Years to 24 Years
Countries
Canada
Sponsor
University of Calgary
Condition
ADHD
Other study type icon
RecruitingNCT06929533

Pharmacogenomics-Supported Psychotropic Prescribing study

This study is looking at whether questionnaires and follow-up can help people with Mental Disorder, Pharmacogenetics, Adverse Drug Reaction, or Effectiveness. Participants receive a study treatment and complete follow-up visits and assessments.

In Winnipeg
OCDDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.Over 18 Years
Countries
Canada
Sponsor
University of Manitoba
Condition
OCD
Biological study icon
RecruitingNCT05490732

Pharmacokinetic Modeling of Methadone

This summary needs review. Please check the official study record and contact the research team for details.

In Montpellier
AddictionBiologicalFrom 18 Years to 99 Years
Countries
France
Sponsor
University Hospital, Montpellier
Condition
Addiction
Drug study icon
RecruitingNCT04278404

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

This observational study is following people with Coronavirus Infection, Pulmonary Arterial Hypertension, Urinary Tract Infections in Children, or Hypertension to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Phoenix
ADHDDrugA study involving a medication or substance.From 0 Years to 20 Years
Countries
United States, Canada
Sponsor
Duke University
Condition
ADHD
Drug study icon
RecruitingNCT06410599

Pharmacologic Treatment Augmentation in Chronic Depression

This study is comparing Ketamine with placebo for people with depression. Participants receive Ketamine or placebo and complete study visits and assessments.

Multiple locations, including Tübingen
DepressionDrugFrom 18 Years to 64 Years
Countries
Germany
Sponsor
University Hospital Tuebingen
Condition
Depression
Other study type icon
RecruitingISRCTN73221288

Pharmacological treatment of depression

This study is looking at whether 1 can help people with Depression or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In Netherlands
DepressionOtherFrom 18 Years to 65 Years
Countries
Netherlands
Sponsor
Erasmus Medical Center (The Netherlands)
Condition
Depression
Drug study icon
RecruitingISRCTN75768415

Pharmacological treatment of Depression: Phase II Lithium addition

This study is testing a medication approach for people with Depression or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In Netherlands
DepressionOtherFrom 18 Years to 65 Years
Countries
Netherlands
Sponsor
Erasmus Medical Center (The Netherlands)
Condition
Depression
Other study type icon
RecruitingISRCTN36607067

Pharmacological treatment of psychotic depression

This study is looking at whether Trial treatments: 1 can help people with In- with psychotic depression, Mental and Behavioural Disorders, or Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In Netherlands
Depression, SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Center Utrecht (UMCU) (The Netherlands)
Condition
Depression, Schizophrenia
Drug study icon
RecruitingNCT06374277

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

This study is comparing Med AAAction intervention with Usual care Intervention for people with depression or anxiety. Participants receive Med AAAction intervention or Usual care Intervention and complete study visits and assessments.

Multiple locations, including Knoxville
Anxiety, DepressionOtherOver 18 Years
Countries
United States
Sponsor
University of Tennessee
Condition
Anxiety, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.